This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2dtm
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Thermodynamic and structural analyses of hydrolytic mechanism by catalytic antibodies== | ==Thermodynamic and structural analyses of hydrolytic mechanism by catalytic antibodies== | ||
| - | <StructureSection load='2dtm' size='340' side='right' caption='[[2dtm]], [[Resolution|resolution]] 2.25Å' scene=''> | + | <StructureSection load='2dtm' size='340' side='right'caption='[[2dtm]], [[Resolution|resolution]] 2.25Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[2dtm]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2DTM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2DTM FirstGlance]. <br> | <table><tr><td colspan='2'>[[2dtm]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2DTM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2DTM FirstGlance]. <br> | ||
| Line 33: | Line 33: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Fujii, I]] | [[Category: Fujii, I]] | ||
Revision as of 08:20, 11 March 2020
Thermodynamic and structural analyses of hydrolytic mechanism by catalytic antibodies
| |||||||||||

